Abstract
The expression of proteins which do not express well on their own can be enhanced by linking them to human serum albumin (HSA) or antibody crystallizable fragment (Fc). The constructs shown here are designed to secrete the proteins after transient transfection of mammalian cell lines. The fusion partners are appended to the N-terminus of the proteins and contain a linker designed to be proteolytically cleaved. Transient transfection and purification protocols are provided as well as experimental results with five interleukins.
Keywords: Fusion proteins, protein expression, transfection, 2936E cells, polyethyleneimine, PEI
Current Pharmaceutical Biotechnology
Title: Fusion Partners as a Tool for the Expression of Difficult Proteins in Mammalian Cells
Volume: 11 Issue: 3
Author(s): Jue Zhang, Jane Carter, Sophia Siu, Jason W. O'Neill, Andrew H. Gates, John Delaney and Christopher Mehlin
Affiliation:
Keywords: Fusion proteins, protein expression, transfection, 2936E cells, polyethyleneimine, PEI
Abstract: The expression of proteins which do not express well on their own can be enhanced by linking them to human serum albumin (HSA) or antibody crystallizable fragment (Fc). The constructs shown here are designed to secrete the proteins after transient transfection of mammalian cell lines. The fusion partners are appended to the N-terminus of the proteins and contain a linker designed to be proteolytically cleaved. Transient transfection and purification protocols are provided as well as experimental results with five interleukins.
Export Options
About this article
Cite this article as:
Zhang Jue, Carter Jane, Siu Sophia, W. O'Neill Jason, H. Gates Andrew, Delaney John and Mehlin Christopher, Fusion Partners as a Tool for the Expression of Difficult Proteins in Mammalian Cells, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791111898
DOI https://dx.doi.org/10.2174/138920110791111898 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Use of Clopidogrel
Current Pharmaceutical Design Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment
Current Drug Targets <i>Plasmodium falciparum</i> Heat Shock Protein 70 Lacks Immune Modulatory Activity
Protein & Peptide Letters Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment
Current Rheumatology Reviews Antiplatelet Therapy And Percutaneous Coronary Interventions
Current Cardiology Reviews Dual Acting Anti-Inflammatory Drugs
Current Topics in Medicinal Chemistry Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Granulocyte Colony-Stimulating Factor (G-CSF) in the Mechanism of Human Ovulation and its Clinical Usefulness
Current Medicinal Chemistry The SAPHO Syndrome and Genetics – discoveries in Need of Replication
Current Rheumatology Reviews Peripheral Mononuclear Cell Rejuvenation for Senescence Surveillance in Alzheimer Disease
Current Pharmaceutical Design From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Current Neuropharmacology RNA Interference and Potential Applications
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Controversies and Current Approaches in the Diagnosis of Prediabetes and Diabetes Mellitus)
Current Diabetes Reviews Editorial (Mini Thematic Issue: Immunotherapy – A Pivotal Mechanism in the Fight of Cancer)
Reviews on Recent Clinical Trials CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders
Current Drug Targets Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery
Current Drug Metabolism Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective
Current Pharmaceutical Biotechnology Alphaviruses and their Derived Vectors as Anti-Tumor Agents
Current Cancer Drug Targets Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy
Recent Patents on Biomarkers